Literature DB >> 7351504

Dermatosparaxis in a Himalayan cat: I. Biochemical studies of dermal collagen.

D F Counts, P H Byers, K A Holbrook, G A Hegreberg.   

Abstract

Dermatosparaxis, a genetic disease, results from the deficiency of the NH2 procollagen peptidase, an enzyme which removes the NH2-terminal nontriple-helical extensions from procollagen. We have identified a Himalayan cat which has deficient amino terminal procollagen peptidase activity. The partially processed precursor chains pNalpha 1 (110,000 daltons) and pNalpha 2 (99,000 daltons) were identified by sodium dodecyl sulfate electrophoresis. In contrast to that from a normal animal, the 20,000 xg supernatant of a skin homogenate failed to convert pNcollagen to collagen. Amino acid analysis of pNalpha 1 and pNalapha 2 chains demonstrated the presence of cysteine and a lower percentage of hydroxyprolyl and glycyl residues due to the presence of the amino terminal extensions. The disorder in this animal is milder than that in sheep and cattle which is reflected in the longer survival and relatively smaller proportion of pNalpha chains in skin. The defect was also demonstrated by skin fibroblasts in culture.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7351504     DOI: 10.1111/1523-1747.ep12519991

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  10 in total

1.  Human dermatosparaxis: a form of Ehlers-Danlos syndrome that results from failure to remove the amino-terminal propeptide of type I procollagen.

Authors:  L T Smith; W Wertelecki; L M Milstone; E M Petty; M R Seashore; I M Braverman; T G Jenkins; P H Byers
Journal:  Am J Hum Genet       Date:  1992-08       Impact factor: 11.025

Review 2.  Learning how mutations in type I collagen genes cause connective tissue disease.

Authors:  K E Kadler
Journal:  Int J Exp Pathol       Date:  1993-08       Impact factor: 1.925

3.  Alterations of collagen in lichen amyloidosus.

Authors:  D Tsambaos; R Bolling
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

4.  Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility.

Authors:  K G Danielson; H Baribault; D F Holmes; H Graham; K E Kadler; R V Iozzo
Journal:  J Cell Biol       Date:  1997-02-10       Impact factor: 10.539

5.  Independent COL5A1 Variants in Cats with Ehlers-Danlos Syndrome.

Authors:  Sarah Kiener; Neoklis Apostolopoulos; Jennifer Schissler; Pascal-Kolja Hass; Fabienne Leuthard; Vidhya Jagannathan; Carole Schuppisser; Sara Soto; Monika Welle; Ursula Mayer; Tosso Leeb; Nina M Fischer; Sabine Kaessmeyer
Journal:  Genes (Basel)       Date:  2022-04-29       Impact factor: 4.141

6.  Studies of the intercellular matrix of growth plates from dwarf and homozygous nonaffected Alaskan Malamutes: collagen and hexosamine.

Authors:  S A Bingel; R D Sande; D F Counts
Journal:  Calcif Tissue Int       Date:  1980       Impact factor: 4.333

7.  The clinical features of Ehlers-Danlos syndrome type VIIB resulting from a base substitution at the splice acceptor site of intron 5 of the COL1A2 gene.

Authors:  A J Carr; A A Chiodo; J M Hilton; C W Chow; A Hockey; W G Cole
Journal:  J Med Genet       Date:  1994-04       Impact factor: 6.318

8.  A mutation in the pro alpha 2(I) gene (COL1A2) for type I procollagen in Ehlers-Danlos syndrome type VII: evidence suggesting that skipping of exon 6 in RNA splicing may be a common cause of the phenotype.

Authors:  N S Vasan; H Kuivaniemi; B E Vogel; R R Minor; J A Wootton; G Tromp; R Weksberg; D J Prockop
Journal:  Am J Hum Genet       Date:  1991-02       Impact factor: 11.025

9.  Expanding the clinical and mutational spectrum of the Ehlers-Danlos syndrome, dermatosparaxis type.

Authors:  Tim Van Damme; Alain Colige; Delfien Syx; Cecilia Giunta; Uschi Lindert; Marianne Rohrbach; Omid Aryani; Yasemin Alanay; Pelin Özlem Simsek-Kiper; Hester Y Kroes; Koen Devriendt; Marc Thiry; Sofie Symoens; Anne De Paepe; Fransiska Malfait
Journal:  Genet Med       Date:  2016-01-14       Impact factor: 8.822

10.  Identification of Two Independent COL5A1 Variants in Dogs with Ehlers-Danlos Syndrome.

Authors:  Anina Bauer; John F Bateman; Shireen R Lamandé; Eric Hanssen; Shannon G M Kirejczyk; Mark Yee; Ali Ramiche; Vidyha Jagannathan; Monika Welle; Tosso Leeb; Fiona L Bateman
Journal:  Genes (Basel)       Date:  2019-09-21       Impact factor: 4.096

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.